**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 62637-99-4 |Lead (II) cyclohexanebutyrate | | 263-663-7 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 20/22 33 61 62
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. May cause harm to the unborn child. Possible risk of
impaired fertility.Toxic.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Prolonged and/or repeated contact may
cause irritation and/or dermatitis.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea.
Inhalation:
Harmful if inhaled. May cause respiratory tract irritation. May
cause effects similar to those described for ingestion.
Chronic:
Chronic exposure to lead may result in plumbism which is
characterized by lead line in gum, headache, muscle weakness, mental
changes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Wash mouth out with water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Antidote:
The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating
agent should be determined by qualified medical personnel. The use of
d-Penicillamine as a chelating agent should be determined by
qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dust can be an explosion hazard when exposed to
heat or flame.
Extinguishing Media:
For small fires, use water spray, dry chemical, carbon dioxide or
chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Avoid contact with eyes, skin, and
clothing. Do not breathe dust, vapor, mist, or gas. Do not get in
eyes, on skin, or on clothing. Avoid ingestion and inhalation. Use
only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Keep from contact with oxidizing materials.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne
concentrations below the permissible exposure limits.
Exposure Limits
CAS# 62637-99-4:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: Odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: soluble in xylene, 2-ethylhexanoic acid
Specific Gravity/Density:
Molecular Formula: C20H34O4Pb
Molecular Weight: 545.69
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents and strong acids.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, lead/lead oxides.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 62637-99-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Lead (II) cyclohexanebutyrate -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
IMO
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
RID/ADR
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 62637-99-4: No information available.
Canada
CAS# 62637-99-4 is listed on Canada's DSL List.
CAS# 62637-99-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 62637-99-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
l-Cysteic Acid Monohydrate, 99+%
| 23537-25-9 |
|
1-Hexanesulfonic acid sodium salt premixed concentrate
| |
|
N-Alpha-Carbobenzyloxy-L-Asparagine, 98%
| 2304-96-3 |
|
Ytterbium atomic absorption standard solution, 1 mg/ml yb in 2% hno3
| |
|
Bromotrichloromethane, 99%
| 75-62-7 |
|
Dicyclopentadiene, 95%, stabilized with 100-200 ppm
| 77-73-6 |
|
3-Amino-1-propanesulfonic acid, 95%
| 3687-18-1 |
|
Copper(ii) fluoride, anhydrous, 99+%
| 7789-19-7 |
|
2-Chloro-4-Fluorophenylacetic Acid
| 177985-32-9 |
|
Cyclopropyl Phenyl Sulfide
| 14633-54-6 |
|
BOC-L-Tyrosine, 99+%
| 3978-80-1 |
|
1,8-Octanediol, 99+%
| 629-41-4 |
|
3-Thiophenecarboxylic acid, 99%
| 88-13-1 |
|
1,2,3-Trimethylbenzene, Tech., 90%
| 526-73-8 |
|
Molybdenum(v) chloride, 98%
| 10241-05-1 |
|
2-Dimethylaminoethyl Acetate
| 1421-89-2 |
|
4-Benzyl-4-Hydroxypiperidine, 95+%(GC)
| 51135-96-7 |
|
8-Chloroquinoline, 99% (gc)
| 611-33-6 |
|
2-Ethyl-3,5(6)-dimethylpyrazine,99.5+%
| 27043-05-6 |
|
p-Ethoxybenzyl Alcohol, 98%
| 6214-44-4 |
|
2,3-Dichlorothiophene, 97%
| 17249-79-5 |
|
Tropolone, 98%
| 533-75-5 |
|
1,3-Difluorobenzene, 99+%
| 372-18-9 |
|
2-Methylundecanal, 95%
| 110-41-8 |
|
2-Ethyl-2-methyl-1,3-dioxolane, 99%
| 126-39-6 |
|
Bromoethane, 98%
| 74-96-4 |
|
1,3,5-Triphenylbenzene, 97%
| 612-71-5 |
|
1-Tetradecene, 92%
| 1120-36-1 |
|
9,10-Anthracenedicarboxaldehyde, 95% (UV-Vis)
| 7044-91-9 |
|
Lead cyclohexanebutyrate
| 62637-99-4 |
|
1-Butanethiol, 99+%
| 109-79-5 |
|
L-(+)-Homoarginine hydrochloride, 99+%
| 1483-01-8 |
|
3,4-(Methylenedioxy)-aniline, 97%
| 14268-66-7 |
|
(2-Chloroethyl)benzene, 99%
| 622-24-2 |
|
Poly(propylene), chlorinated
| 68442-33-1 |
|
Dodecyl aldehyde, 96%, stabilized with 0.1% BHA
| 112-54-9 |
|
N,N'-Diallyltartardiamide
| 58477-85-3 |
|
5,6,7,8-Tetrahydro-2-naphthol, 98%
| 1125-78-6 |
|
Cyclodecanone, 97%
| 1502-06-3 |
|
4-Amino-1-butanol, 98%
| 13325-10-5 |
|
4-Aminoveratrole, 98%
| 6315-89-5 |
|
2-Bromo-4-nitrotoluene, 98%
| 7745-93-9 |
|
Pulegone (Pract), 88% (GC)
| 89-82-7 |
|
Diethyl suberate, 98%
| 2050-23-9 |
|
beta-Bromostyrene, mixture of cis/trans isomers, 97%
| 103-64-0 |
|
Naphthenic acids (pract)
| 1338-24-5 |
|
S(+)-1,3-Butanediol, 98%
| 24621-61-2 |
|
5-Bromo-1,2,4-trimethylbenzene, 99%
| 5469-19-2 |
|
alpha-D(+)-Melibiose hydrate, 99+%
| 585-99-9 |
|
O-Tolualdehyde 98% (Stabilized with 0.1 % H.Q.)
| 529-20-4 |
|
|